Fundraising FoxLacerta Therapeutics
Alachua, US · Founded 2017 · Delaware corporation · 1 known investors
Find your way into Lacerta Therapeutics
Sign up to see every warm intro you have to Lacerta Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lacerta Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Lacerta Therapeutics was founded in 2017 by Nicholas Muzyczka.
NM
Nicholas MuzyczkaFounder
JR
James RuscheNamed on SEC filing
JD
Joseph D. ReddyNamed on SEC filing
BB
Barry ByrneNamed on SEC filing
KW
Kenneth WarringtonNamed on SEC filing
SZ
Sergei ZolotukhinNamed on SEC filing
Investors · 1
Also in the syndicate · 1
Sarepta
Reported raises · per SEC filings
Form D private placements$500K disclosed across 1 of 2 rounds · 2017–2018
▶$30MofferedAug 2018 · BiotechnologyRule 506(b)
▶$30MofferedAug 2018 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James RuscheDirector
- Nicholas MuzyczkaDirector
- Joseph D. ReddyExecutive Officer, Director, Promoter
- Barry ByrneDirector, Promoter
- Kenneth WarringtonExecutive Officer, Promoter
- Sergei ZolotukhinDirector, Promoter
- Offering amount
- $30M
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$500KraisedAug 2018 · 6 investors · BiotechnologyRule 506(b)
▶$500KraisedAug 2018 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph D. ReddyExecutive Officer, Director, Promoter
- Kenneth WarringtonExecutive Officer, Promoter
- Nicholas MuzyczkaDirector
- Sergei ZolotukhinDirector, Promoter
- James RuscheDirector
- Barry ByrneDirector, Promoter
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Lacerta Therapeutics?
- Lacerta Therapeutics was founded by Nicholas Muzyczka in 2017.
- How much funding has Lacerta Therapeutics raised?
- Lacerta Therapeutics has disclosed $500K raised across 1 of its 2 known rounds.
- Where is Lacerta Therapeutics headquartered?
- Lacerta Therapeutics is headquartered in Alachua, US.